MUMBAI, India, Aug. 12 -- Intellectual Property India has published a patent application (202637050588 A) filed by Oyster Point Pharma, Inc. on April 21, 2026, for Insulin-Like Growth Factor-1 Receptor (igf1r) Antibodies And Related Methods Of Treatment.
Inventor includes Carlson, Eric C..
The application for the patent was published on August 07, 2026, under issue no. 32/2026.
Abstract: Provided herein are antibodies and antigen-binding fragments thereof configured to specifically bind to Insulin-like Growth Factor- 1 ("IGF1R"). Nucleic acid molecules encoding the same, pharmaceutical compositions, and methods of treatment based on administration or expression of the anti-IGF1R antibodies and antigen- binding fragments described herein, are also provided.
Disclaimer: Curated by HT Syndication.
